(Q38677841)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

title

Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

triple-negative breast cancer

25 March 2020

main subject

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Luca Moscetti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Paolo Marchetti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Luisa Carbognin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Laura Iezzi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Andrea Botticelli

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Nicola Tinari

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Maddalena Barba

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Michele De Tursi

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Antonio Giordano

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Gennaro Ciliberto

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Clara Natoli

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Patrizia Vici

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1

Teresa Gamucci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

2

Laura Pizzuti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

4

Lucia Mentuccia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

5

Angela Vaccaro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

9

Andrea Michelotti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

11

Alessandra Cassano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

12

Antonino Grassadonia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

13

Antonio Astone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

15

Emanuela Magnolfi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

22

Elisabetta Landucci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

23

Francesca Conti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

24

Giuseppe Sanguineti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

author name string

Luigi Di Lauro

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Domenico Sergi

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Paola Fuso

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Marcello Maugeri-Saccà

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

Gianni Iafrate

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

publication date

27 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cellular Physiology

25 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

volume

233

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

page(s)

2313-2323

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy

25 March 2020

cites work

1 reference

Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

21 January 2018

1 reference

Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer.

21 January 2018

1 reference

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

21 January 2018

1 reference

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

21 January 2018

1 reference

Both carboplatin and bevacizumab improve pathological complete remission rate in neoadjuvant treatment of triple negative breast cancer: a meta-analysis

21 January 2018

1 reference

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

21 January 2018

1 reference

Strategies for developing Ki67 as a useful biomarker in breast cancer

21 January 2018

1 reference

Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2- breast cancer: results from two prospective trials.

21 January 2018

1 reference

Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44).

21 January 2018

1 reference

Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy

21 January 2018

1 reference

Effect of neoadjuvant anthracycline-taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study

21 January 2018

1 reference

The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients.

21 January 2018

1 reference

Triple-negative breast cancer: role of specific chemotherapy agents

21 January 2018

1 reference

Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of feasibility and rates of pathologic complete response

21 January 2018

1 reference

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

21 January 2018

1 reference

Triple-negative breast cancer: molecular subtypes and new targets for therapy.

21 January 2018

1 reference

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes

21 January 2018

1 reference

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer

21 January 2018

1 reference

Triple negative breast cancer: unmet medical needs

21 January 2018

1 reference

Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.

21 January 2018

1 reference

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts.

21 January 2018

1 reference

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40

21 January 2018

1 reference

Frequent pathologic complete responses in aggressive stages II to III breast cancers with every-4-week carboplatin and weekly paclitaxel with or without trastuzumab: a Brown University Oncology Group Study

21 January 2018

1 reference

Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy

21 January 2018

1 reference

Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword

21 January 2018

1 reference

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†.

21 January 2018

1 reference

Ki67 measured after neoadjuvant chemotherapy for primary breast cancer

21 January 2018

1 reference

Neoadjuvant carboplatin in patients with triple-negative and HER2-positive early breast cancer (GeparSixto; GBG 66): a randomised phase 2 trial

21 January 2018

1 reference

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.

21 January 2018

1 reference

Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy

21 January 2018

1 reference

Ki67 in breast cancer: prognostic and predictive potential

21 January 2018

1 reference

Better pathologic complete response and relapse-free survival after carboplatin plus paclitaxel compared with epirubicin plus paclitaxel as neoadjuvant chemotherapy for locally advanced triple-negative breast cancer: a randomized phase 2 trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCP.26103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28710865%20AND%20SRC:MED&resulttype=core&format=json

25 March 2020

1 reference